Predicting pathological complete response based on weakly and semi-supervised joint learning in breast cancer multi-parametric MRI
Hao, X., Xu, H., Zhao, N., Yu, T., Hämäläinen, T., & Cong, F. (2024). Predicting pathological complete response based on weakly and semi-supervised joint learning in breast cancer multi-parametric MRI. Biomedical Signal Processing and Control, 93, Article 106164. https://doi.org/10.1016/j.bspc.2024.106164
Julkaistu sarjassa
Biomedical Signal Processing and ControlPäivämäärä
2024Pääsyrajoitukset
Embargo päättyy: 2026-08-01Pyydä artikkeli tutkijalta
Tekijänoikeudet
© 2024 the Authors
Neoadjuvant chemotherapy (NAC) is the primary treatment used to reduce the tumor size in early breast cancer. Patients who achieve a pathological complete response (pCR) after NAC treatment have a significantly higher five-year survival rate. However, accurately predicting whether patients could achieve pCR remains challenging due to the limited availability of manually annotated MRI data. This study develops a weakly and semi-supervised joint learning model that integrates multi-parametric MR images to predict pCR to NAC in breast cancer patients. First, the attention-based multi-instance learning model is designed to characterize the representation of multi-parametric MR images in a weakly supervised learning setting. The Mean-Teacher learning framework is then developed to locate tumor regions for extracting radiochemical parameters in a semi-supervised learning setting. Finally, all extracted MR imaging features are fused to predict pCR to NAC. Our experiments were conducted on a cohort of 442 patients with multi-parametric MR images and NAC outcomes. The results demonstrate that our proposed model, which leverages multi-parametric MRI data, provides the AUC value of over 0.85 in predicting pCR to NAC, outperforming other comparative methods.
...
Julkaisija
ElsevierISSN Hae Julkaisufoorumista
1746-8094Asiasanat
Julkaisu tutkimustietojärjestelmässä
https://converis.jyu.fi/converis/portal/detail/Publication/207426349
Metadata
Näytä kaikki kuvailutiedotKokoelmat
Lisätietoja rahoituksesta
This work was supported by National Natural Science Foundation of China (Grant No. 82102135), the Fundamental Research Funds for the Central Universities (Grant No. DUT22YG114, Grant No. DUT23YG130), the Natural Science Foundation of Liaoning Province (Grant No. 2022-YGJC-36) and the scholarship from the China Scholarship Council (No. 202006060060).Lisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells
Nafie, Mohamed S.; Al-Majid, Abdullah Mohammed; Ali, M.; Alayyaf, Abdulmajeed Abdullah; Haukka, Matti; Ashraf, Sajda; Ul-Haq, Zaheer; El-Faham, Ayman; Barakat, Assem (Frontiers Media, 2024)Cancer represents a global challenge, and the pursuit of developing new cancer treatments that are potent, safe, less prone to drug resistance, and associated with fewer side effects poses a significant challenge in cancer ... -
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival
Repo, Heli; Gurvits, Natalia; Löyttyniemi, Eliisa; Nykänen, Marjukka; Lintunen, Minnamaija; Karra, Henna; Kurki, Samu; Kuopio, Teijo; Talvinen, Kati; Söderström, Mirva; Kronqvist, Pauliina (BioMed Central, 2017)Background: PTTG1-interacting protein (PTTG1IP) is an oncogenic protein, which participates in metaphase-anaphase transition of the cell cycle through activation of securin (PTTG1). PTTG1IP promotes the shift of securin ... -
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer
Jääskeläinen, Minna M.; Tiainen, Satu; Siiskonen, Hanna; Ahtiainen, Maarit; Kuopio, Teijo; Rönkä, Aino; Kettunen, Tiia; Hämäläinen, Kirsi; Rilla, Kirsi; Harvima, Ilkka; Mannermaa, Arto; Auvinen, Päivi (Springer, 2023)Purpose In HER2-positive (HER2 +) breast cancer, tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) may influence the efficacy of the HER2-antibody trastuzumab and the patient’s outcome. In this ... -
Factors predicting long-term physical activity of breast cancer survivors. 5-year-follow-up of the BREX exercise intervention study
Kokkonen, Kristiina; Kellokumpu-Lehtinen, Pirkko-Liisa; Kankaanpää, Markku; Nikander, Riku; Penttinen, Heidi Maria; Utriainen, Meri; Vehmanen, Leena; Huovinen, Riikka; Kautiainen, Hannu; Blomqvist, Carl; Saarto, Tiina (Informa UK Limited, 2022)Background The benefits of exercise training are well documented among breast cancer (BC) survivors. Patients decrease their physical activity during treatment, and many fail to regain their previous exercise levels. There ... -
Ranking attention multiple instance learning for lymph node metastasis prediction on multicenter cervical cancer MRI
Jin, Shan; Xu, Hongming; Dong, Yue; Wang, Xiaofeng; Hao, Xinyu; Qin, Fengying; Wang, Ranran; Cong, Fengyu (Wiley, 2024)Purpose In the current clinical diagnostic process, the gold standard for lymph node metastasis (LNM) diagnosis is histopathological examination following surgical lymphadenectomy. Developing a non-invasive and preoperative ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.